Blog
RSS FeedPosted by Michael Wonder on 11 Jul 2020
Trump will sign three executive orders on lowering drug prices: chief of staff
10 July 2020 - President Donald Trump will sign three executive orders on lowering prescription drug prices, White House Chief ...
Posted by Michael Wonder on 11 Jul 2020
How can cancer drug prices better match their benefits? Germany offers a cost-saving model
10 July 2020 - After Germany revamped its approach to purchasing medicines a decade ago, the prices negotiated by the ...
Posted by Michael Wonder on 09 Jul 2020
Despite the pandemic, prices for many drugs keep rising
9 July 2020 - Despite the economic hardships the COVID-19 pandemic has created for many Americans, drug makers raised list ...
Posted by Michael Wonder on 08 Jul 2020
Drug prices steadily rise amid pandemic, data shows
7 July 2020 - Some drugmakers have delayed or staggered increases amid increased scrutiny and the fear of catching President Donald ...
Posted by Michael Wonder on 07 Jul 2020
Did a pharma trade group try to sabotage a Dutch government report on compulsory licensing?
7 July 2020 - Dutch government commission on compulsory licensing was nearly sabotaged last month after one of its members ...
Posted by Michael Wonder on 07 Jul 2020
Lessons from the impact of price regulation on the pricing of anti-cancer drugs in Germany
7 July 2020 - Worldwide spending on prescription drugs has increased dramatically in recent years. Although this increase has been particularly ...
Posted by Michael Wonder on 07 Jul 2020
Unsustainable low prices causing generic drug market failure leading to supply chain disruptions and shortages
6 July 2020 - Ongoing disruptions in the globalised pharma supply chains causing drug shortages in the United States are ...
Posted by Michael Wonder on 06 Jul 2020
Mylan prices its generic remdesivir in India at $64 per 100 mg vial
6 July 2020 - Mylan will launch a generic version of Gilead Sciences’ COVID-19 anti-viral remdesivir in India at 4,800 rupees, ...
Posted by Michael Wonder on 06 Jul 2020
CMS’s proposed Medicaid best price loophole for value based purchasing of drugs
6 July 2020 - For three decades, US pharmaceutical companies have agreed to sell their products to Medicaid programs at ...
Posted by Michael Wonder on 06 Jul 2020
Will we be hostages to drug makers’ Covid vaccine pricing?
6 July 2020 - The United States is the only developed nation unable to balance cost, efficacy and social good in ...
Posted by Michael Wonder on 02 Jul 2020
$600 or $3,120? Gilead puts a price tag on COVID-19 relief
2 July 2020 - The pharmaceutical industry has been stubbornly opaque about how much it truly spends on research and development. ...
Posted by Michael Wonder on 02 Jul 2020
ICER publishes white paper on alternative policies for drug and vaccine pricing during a pandemic, announces cross-stakeholder discussion series
2 July 2020 - The Institute for Clinical and Economic Review today published a white paper to inform public and policy ...
Posted by Michael Wonder on 01 Jul 2020
Some U.S. government contracts for COVID-19 research could skirt affordable pricing laws
1 July 2020 - A new report finds that the U.S. government awarded several drug makers contracts for coronavirus research ...
Posted by Michael Wonder on 30 Jun 2020
Companies have raised prices on 245 drugs during pandemic, advocacy group says
29 June 2020 - Pharmaceutical companies have raised prices on 245 drugs since the first U.S. coronavirus case was reported ...
Posted by Michael Wonder on 30 Jun 2020
Canada federal court dismisses drug makers' plea challenging drug price rules
30 June 2020 - The federal court of Canada on Monday dismissed a plea by drug makers challenging the Canadian ...